FindTrial
Sign In

Establishment and evaluation of a comprehensive model for predicting postoperative hepatic insufficiency in patients with hepatocellular carcinoma associated with hepatitis b

Establishment and evaluation of a comprehensive model for predicting postoperative hepatic insufficiency in patients with hepatocellular carcinoma associated with hepatitis b

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022850
Enrollment
Unknown
Registered
2019-04-28
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)

Interventions

hepatic insufficiency group and non-insufficiency group:no intervention

Sponsors

Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Hepatitis b related liver cancer patients; 2. Cases confirmed by pathology as hepatocellular carcinoma after hepatectomy; 2. Indocyanine green excretion test was performed preoperatively. 3. Preoperative CT examination; No obvious cardiopulmonary disease. Generally good.

Exclusion criteria

Exclusion criteria: 1. Postoperative pathology confirmed metastatic liver cancer or other tumors; 2. Received preoperative chemoradiotherapy or interventional therapy; 3. Pregnant women.

Design outcomes

Primary

MeasureTime frame
postoperative liver dysfunction;—

Countries

China

Contacts

Public ContactSongqing He

Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Guangxi Medical University

dr_hesongqing@163.com+86 0771 5356568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026